[HTML][HTML] Targeting Akt in cancer for precision therapy

H Hua, H Zhang, J Chen, J Wang, J Liu… - Journal of Hematology & …, 2021 - Springer
Biomarkers-guided precision therapeutics has revolutionized the clinical development and
administration of molecular-targeted anticancer agents. Tailored precision cancer therapy …

[HTML][HTML] The Akt pathway in oncology therapy and beyond

GM Nitulescu, M Van De Venter… - International …, 2018 - spandidos-publications.com
Protein kinase B (Akt), similar to many other protein kinases, is at the crossroads of cell
death and survival, playing a pivotal role in multiple interconnected cell signaling …

[HTML][HTML] Maximising the potential of AKT inhibitors as anti-cancer treatments

JS Brown, U Banerji - Pharmacology & therapeutics, 2017 - Elsevier
Abstract PI3K/AKT signalling is commonly disrupted in human cancers, with AKT being a
central component of the pathway, influencing multiple processes that are directly involved …

Deregulation of the Akt pathway in human cancer

E Tokunaga, E Oki, A Egashira… - Current cancer drug …, 2008 - ingentaconnect.com
Akt (protein kinase B) is a serine/threonine kinase which is a central regulator of widely
divergent cellular processes including proliferation, differentiation, migration, survival and …

Targeting AKT for cancer therapy

M Shariati, F Meric-Bernstam - Expert opinion on investigational …, 2019 - Taylor & Francis
Introduction: Targeted therapies in cancer aim to inhibit specific molecular targets
responsible for enhanced tumor growth. AKT/PKB (protein kinase B) is a serine threonine …

[HTML][HTML] Akt: a key transducer in cancer

PJ Tsai, YH Lai, RK Manne, YS Tsai… - Journal of biomedical …, 2022 - Springer
Growth factor signaling plays a pivotal role in diverse biological functions, such as cell
growth, apoptosis, senescence, and migration and its deregulation has been linked to …

The Akt pathway: molecular targets for anti-cancer drug development

CS Mitsiades, N Mitsiades… - Current cancer drug …, 2004 - ingentaconnect.com
The serine/threonine kinase Akt functions intracellularly as a cardinal nodal point for a
constellation of converging upstream signaling pathways, which involve stimulation of …

Akt inhibitors in clinical development for the treatment of cancer

SK Pal, K Reckamp, H Yu, RA Figlin - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: The evolution of targeted therapies is dependent upon identification
of cellular moieties that can be pharmacologically modulated. As one such example, the …

The Akt/PKB pathway: molecular target for cancer drug discovery

JQ Cheng, CW Lindsley, GZ Cheng, H Yang… - Oncogene, 2005 - nature.com
The serine/threonine kinase Akt/PKB pathway presents an exciting new target for molecular
therapeutics, as it functions as a cardinal nodal point for transducing extracellular (growth …

A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities

A Bellacosa, JR Testa, R Moore… - Cancer biology & therapy, 2004 - Taylor & Francis
More than a decade after their discovery, the three AKT kinase family members have
emerged as central players in the signaling cascades that regulate cell growth, proliferation …